Evidence in practice

Archives of Disease in Childhood

Volumn 90, Issue 8, 2005, Pages 849-852

  Akobeng, A K ^a  

^a BOOTH HALL CHILDREN S HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; INFLIXIMAB;

CLINICAL PRACTICE; COST; CROHN DISEASE; EVIDENCE BASED MEDICINE; HEALTH CARE POLICY; HUMAN; PATIENT CARE; PRIORITY JOURNAL; REVIEW; TREATMENT OUTCOME;

ANTIBODIES, MONOCLONAL; CHILD; CHILD WELFARE; COSTS AND COST ANALYSIS; CROHN DISEASE; DECISION MAKING; EVIDENCE-BASED MEDICINE; FAMILY PRACTICE; GASTROINTESTINAL AGENTS; HUMANS; INFORMATION STORAGE AND RETRIEVAL; RISK ASSESSMENT;

EID: 23144447286     PISSN: 00039888     EISSN: 14682044     Source Type: Journal    
DOI: 10.1136/adc.2004.058248     Document Type: Review

References (14)

1. Akobeng AK. Evidence based child health. 1. Principles of evidence based medicine. Arch Dis Child 2005;90:837-40.
2. Akobeng AK, Zachos M. Tumor necrosis factor-alpha antibody for induction of remission in Crohn's disease. The Cochrane Database of Systematic Reviews 2003: issue 4.
3. Targan SR, Hanauer SB, van Deventer SJH, et al. A short term study of chimeric monoclonal antibody cA2 to tumor necrosis factor alpha for Crohn's disease. N Engl J Med 1997;337:1029-35.
4. Baldassano R, Braegger CP, Escher JC, et al. Infliximab (REMICADE) therapy in the treatment of pediatric Crohn's disease. Am J Gastroenterol 2003;98:833-8.
5. D'haens G, van Deventer S, van Hogezand R, et al. Endoscopic and histological healing with infliximab anti-tumor necrosis factor antibodies in Crohn's disease: a European multicenter trial. Gastroenterology 1999;116:1029-34.
6. Critical Appraisal Skills Programme. Appraisal Tools. Oxford, UK. http:// www.phru.nhs.uk/casp/reviews.pdf (accessed 10 Dec 2004).
7. Clarke M, Oxman AD, eds. Cochrane Reviewers' Handbook 4.1.4 (updated October 2001). In: The Cochrane Library, Issue 4, 2001. Oxford: Update software.
8. Jadad AR, Moore RA, Carroll D, et al. Assessing the quality of reports of randomized clinical trials: is blinding necessary? Control Clin Trials 1996;17:1-12.
9. Akobeng AK. Understanding measures of treatment effect in clinical trials. Arch Dis Child 2005;90:54-6.
10. Linzer M, Brown JT, Frazier LM, et al. Impact of a medical journal club on house-staff reading habits, knowledge, and critical appraisal skills. A randomised controlled trial. JAMA 1988;260:2537-41.
11. Kellum JA, Rieker JP, Power M, et al. Teaching critical appraisal during critical care fellowship training: a foundation for evidence-based critical care medicine. Crit Care Med 2000;28:3067-70.
12. Neville AJ, Reiter HI, Eva KW, et al. Critical appraisal turkey shoot: linking critical appraisal to clinical decision making. Acad Med 2000;75:S87-9.
13. Green ML. Evidence-based medicine training in graduate medical education: past, present and future. J Eval Clin Pract 2000;6:121-38.
14. Elnicki DM, Halperin AK, Shockcor WT, et al. Multidisciplinary evidence-based medicine journal clubs: curriculum design and participants' reactions. Am J Med Sci 1999;317:243-6.